Cargando…
Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening
PURPOSE: To assess exome data for pre-emptive pharmacogenetic screening for 203 clinically-relevant pharmacogenetic variant positions from the Pharmacogenomics Knowledgebase and Clinical Pharmacogenetics Implementation Consortium and identify copy number variants (CNVs) in CYP2D6. METHODS: We examin...
Autores principales: | Ng, David, Hong, Celine S., Singh, Larry N., Johnston, Jennifer J., Mullikin, James C., Biesecker, Leslie G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316383/ https://www.ncbi.nlm.nih.gov/pubmed/27537706 http://dx.doi.org/10.1038/gim.2016.105 |
Ejemplares similares
-
Massively-parallel sequencing of genes on a single chromosome: a comparison of solution hybrid selection and flow sorting
por: Teer, Jamie K, et al.
Publicado: (2013) -
Assessing the reproducibility of exome copy number variations predictions
por: Hong, Celine S., et al.
Publicado: (2016) -
Towards massively-parallel analytic capabilities for multielectrode recordings
por: Gardner, Daniel, et al.
Publicado: (2011) -
Exome sequencing: the expert view
por: Biesecker, Leslie G, et al.
Publicado: (2011) -
Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing
por: Matreyek, Kenneth A., et al.
Publicado: (2018)